Viral manipulation of the host immune response

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 54-60

  Christiaansen, Allison ^a   Varga, Steven M ^a,b   Spencer, Juliet V ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE; CYTOKINE; AUTACOID;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY;

ANIMALS; B-LYMPHOCYTE SUBSETS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNOMODULATION; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84936857133     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.06.012     Document Type: Review

References (55)

1. Wilson E.B., Brooks D.G. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol 2011, 350:39-65.
2. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
3. Slobedman B., Barry P.A., Spencer J.V., Avdic S., Abendroth A. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 2009, 83:9618-9629.
4. Ouyang P., Rakus K., van Beurden S.J., Westphal A.H., Davison A.J., Gatherer D., Vanderplasschen A.F. IL-10 encoded by viruses: a remarkable example of independent acquisition of a cellular gene by viruses and its subsequent evolution in the viral genome. J Gen Virol 2014, 95:245-262.
5. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006, 12:1301-1309.
6. Chang W.L., Barry P.A. Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci U S A 2010, 107:22647-22652.
7. Eberhardt M.K., Deshpande A., Chang W.L., Barthold S.W., Walter M.R., Barry P.A. Vaccination against a virus-encoded cytokine significantly restricts viral challenge. J Virol 2013, 87:11323-11331.
8. Jenkins C., Abendroth A., Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 2004, 78:1440-1447.
9. Lin Y.L., Chang P.C., Wang Y., Li M. Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res 2008, 131:213-223.
10. Jenkins C., Garcia W., Abendroth A., Slobedman B. Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology 2008, 370:285-294.
11. Spencer J.V., Lockridge K.M., Barry P.A., Lin G., Tsang M., Penfold M.E., Schall T.J. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002, 76:1285-1292.
12. Jones B.C., Logsdon N.J., Josephson K., Cook J., Barry P.A., Walter M.R. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci U S A 2002, 99:9404-9409.
13. Jenkins C., Garcia W., Godwin M.J., Spencer J.V., Stern J.L., Abendroth A., Slobedman B. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol 2008, 82:3736-3750.
14. Spencer J.V., Cadaoas J., Castillo P.R., Saini V., Slobedman B. Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 2008, 374:164-169.
15. Poole E., Avdic S., Hodkinson J., Jackson S., Wills M., Slobedman B., Sinclair J. Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J Virol 2014, 88:13947-13955.
16. Amanatidou V., Zaravinos A., Apostolakis S., Spandidos D.A. Chemokines in respiratory viral infections: focus on their diagnostic and therapeutic potential. Crit Rev Immunol 2011, 31:341-356.
17. Arnolds K.L., Spencer J.V. CXCR4: a virus's best friend?. Infect Genet Evol 2014, 25:146-156.
18. Alcami A., Lira S.A. Modulation of chemokine activity by viruses. Curr Opin Immunol 2010, 22:482-487.
19. Montaner S., Kufareva I., Abagyan R., Gutkind J.S. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annu Rev Pharmacol Toxicol 2013, 53:331-354.
20. Berson J.F., Long D., Doranz B.J., Rucker J., Jirik F.R., Doms R.W. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996, 70:6288-6295.
21. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
22. Kledal T.N., Rosenkilde M.M., Coulin F., Simmons G., Johnsen A.H., Alouani S., Power C.A., Luttichau H.R., Gerstoft J., Clapham P.R., et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 1997, 277:1656-1659.
23. Yamin R., Kaynan N.S., Glasner A., Vitenshtein A., Tsukerman P., Bauman Y., Ophir Y., Elias S., Bar-On Y., Gur C., et al. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors. PLoS Pathog 2013, 9:e1003568.
24. Yoneda O., Imai T., Goda S., Inoue H., Yamauchi A., Okazaki T., Imai H., Yoshie O., Bloom E.T., Domae N., et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 2000, 164:4055-4062.
25. Campbell J.J., Qin S., Unutmaz D., Soler D., Murphy K.E., Hodge M.R., Wu L., Butcher E.C. Unique subpopulations of CD56+NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001, 166:6477-6482.
26. Qin L., Kufareva I., Holden L.G., Wang C., Zheng Y., Zhao C., Fenalti G., Wu H., Han G.W., Cherezov V., et al. Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine. Science 2015, 347:1117-1122.
27. Vischer H.F., Siderius M., Leurs R., Smit M.J. Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?. Nat Rev Drug Discov 2014, 13:123-139.
28. Chirkova T., Boyoglu-Barnum S., Gaston K.A., Malik F.M., Trau S.P., Oomens A.G., Anderson L.J. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol 2013, 87:13466-13479.
29. Vomaske J., Nelson J.A., Streblow D.N. Human Cytomegalovirus US28: a functionally selective chemokine binding receptor. Infect Disord Drug Targets 2009, 9:548-556.
30. Burg J.S., Ingram J.R., Venkatakrishnan A.J., Jude K.M., Dukkipati A., Feinberg E.N., Angelini A., Waghray D., Dror R.O., Ploegh H.L., et al. Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science 2015, 347:1113-1117.
31. Venkatakrishnan A.J., Deupi X., Lebon G., Tate C.G., Schertler G.F., Babu M.M. Molecular signatures of G-protein-coupled receptors. Nature 2013, 494:185-194.
32. Lares A.P., Tu C.C., Spencer J.V. The human cytomegalovirus US27 gene product enhances cell proliferation and alters cellular gene expression. Virus Res 2013, 176:312-320.
33. Guo H.G., Sadowska M., Reid W., Tschachler E., Hayward G., Reitz M. Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 2003, 77:2631-2639.
34. Nijmeijer S., Leurs R., Smit M.J., Vischer H.F. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Galphai proteins, and constitutively impairs CXCR4 functioning. J Biol Chem 2010, 285:29632-29641.
35. Griffin B.D., Gram A.M., Mulder A., Van Leeuwen D., Claas F.H., Wang F., Ressing M.E., Wiertz E. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol 2013, 190:1672-1684.
36. Lukacs N.W., Moore M.L., Rudd B.D., Berlin A.A., Collins R.D., Olson S.J., Ho S.B., Peebles R.S. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol 2006, 169:977-986.
37. Moore M.L., Chi M.H., Luongo C., Lukacs N.W., Polosukhin V.V., Huckabee M.M., Newcomb D.C., Buchholz U.J., Crowe J.E., Goleniewska K., et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol 2009, 83:4185-4194.
38. Caballero M.T., Serra M.E., Acosta P.L., Marzec J., Gibbons L., Salim M., Rodriguez A., Reynaldi A., Garcia A., Bado D., et al. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest 2015, 125:571-582.
39. Stoppelenburg A.J., de Roock S., Hennus M.P., Bont L., Boes M. Elevated Th17 response in infants undergoing respiratory viral infection. Am J Pathol 2014, 184:1274-1279.
40. Mukherjee S., Lindell D.M., Berlin A.A., Morris S.B., Shanley T.P., Hershenson M.B., Lukacs N.W. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011, 179:248-258.
41. Qin L., Peng D., Hu C., Xiang Y., Zhou Y., Tan Y., Qin X. Differentiation of Th subsets inhibited by nonstructural proteins of respiratory syncytial virus is mediated by ubiquitination. PLoS One 2014, 9:e101469.
42. Munir S., Hillyer P., Le Nouen C., Buchholz U.J., Rabin R.L., Collins P.L., Bukreyev A. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 2011, 7:e1001336.
43. Mason G.M., Jackson S., Okecha G., Poole E., Sissons J.G., Sinclair J., Wills M.R. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog 2013, 9:e1003635.
44. Voo K.S., Peng G., Guo Z., Fu T., Li Y., Frappier L., Wang R.F. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res 2005, 65:1577-1586.
45. Marshall N.A., Vickers M.A., Barker R.N. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J Immunol 2003, 170:6183-6189.
46. Cheung A.K., Gottlieb D.J., Plachter B., Pepperl-Klindworth S., Avdic S., Cunningham A.L., Abendroth A., Slobedman B. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 2009, 114:4128-4137.
47. Mason G.M., Poole E., Sissons J.G., Wills M.R., Sinclair J.H. Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc Natl Acad Sci U S A 2012, 109:14538-14543.
48. Besold K., Wills M., Plachter B. Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition. Virology 2009, 391:5-19.
49. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., Früh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci 1996, 93:10990-10995.
50. Wiertz E.J.H.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
51. Hesse J., Ameres S., Besold K., Krauter S., Moosmann A., Plachter B. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection. J Gen Virol 2013, 94:376-386.
52. Ameres S., Mautner J., Schlott F., Neuenhahn M., Busch D.H., Plachter B., Moosmann A. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion. PLoS Pathog 2013, 9:e1003383.
53. Nothelfer K., Sansonetti P.J., Phalipon A. Pathogen manipulation of B cells: the best defence is a good offence. Nat Rev Micro 2015, 13:173-184.
54. Dougan S.K., Ashour J., Karssemeijer R.A., Popp M.W., Avalos A.M., Barisa M., Altenburg A.F., Ingram J.R., Cragnolini J.J., Guo C., et al. Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature 2013, 503:406-409.
55. Habibi M.S., Jozwik A., Makris S., Dunning J., Paras A., DeVincenzo J.P., de Haan C.A.M., Wrammert J., Openshaw P.J.M., Chiu C. Impaired antibody-mediated protection and defective IgA B cell memory in experimental infection of adults with respiratory syncytial virus. Am J Resp Crit Care Med 2015, 191:1040-1049.